Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.

Integer Holdings Corporation

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Gilead Sciences ...

Current Quarter	$1.7	Next Quarter	$1.35
Current Year	$6.34	Next Year	$6.34
QoQ Growth	-20.6%	YoY Growth	+0.0%
3Y EPS CAGR	+6.8%	Target Price	$91.50
Consensus	Buy	Upside	+25.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ITGR	$72.72	+0.53%	380.89K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ITGR	$72.72	+0.5%	380.89K
3
4
5
6

ITGR

ITGR

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Integer Holdings Corporation Data in Excel

Get Integer Holdings Corporation Data in Excel